The Institute of Human Virology, Nigeria (IHVN) was established in 2004 as an affiliate of the Institute of Human Virology, University of Maryland School of Medicine, Baltimore in the United States of America. It has grown to become a leading local non-governmental organization addressing the HIV/AIDS crises in Nigeria through the development of infrastructure for treatment, care, prevention, and support for people living with and those affected by HIV/AIDS but has now expanded its services to other infectious and non-infectious diseases including, cancer, tuberculosis, malaria and other diseases. IHVN is structured to develop and maintain linkages with local and international organizations in collaborative ways that support the Government of Nigeria's health sector strategic plans. IHVN key technical and funding partners are the Centers for Disease Control and Prevention (CDC) and the Global Fund to Fight AIDS, Tuberculosis and Malaria.
The Institute now offers Anti-retroviral Treatment (ART) services in 476 facilities, PMTCT services in 569 facilities, tuberculosis services in 143 facilities and HIV Counseling and Testing Services in 620 facilities under its ACTIONPlusUp project. Also, through funding from the Global Fund to Fight AIDS, Tuberculosis and Malaria, DR-TB, 16 treatment centers offer treatment for drug resistant tuberculosis, 46 ART services and 164 PMTCT facilities. All these facilities and treatment centers comprise of primary, secondary and tertiary health centers in twenty-six states. At least Fourteen of the hospitals it supports are University Teaching Hospitals. IHVN, which has expanded activities to meet the growing public health challenges in Nigeria, has grown into an organization of about 502 staff members, from initial staff strength of ten.
The HIV program of the Institute focuses on anti-retroviral treatment for adult and children (including pregnant women), laboratory diagnosis and tracking of patient's status, care and support, prevention of mother-to-child transmission of HIV services, HIV counseling and testing, support to orphans and vulnerable children, training and research.
The Institute provides these services in Nasarawa, Kano, Katsina, Delta, Ondo, Ogun, Osun, Benue, Nasarawa and Ekiti states including the Federal Capital Territory. All these have been achieved through funding from the President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention, the Global Fund to Fight AIDS, Tuberculosis and Malaria.
Tuberculosis/Drug Resistant TB Intervention
In the 143 sites that IHVN supports, over 43,000 people living with HIV have been provided with TB treatment.
With funding from the Global Fund to Fight AIDs, Tuberculosis and Malaria, the Institute has tested 149,569 people and given treatment to 2,490 people who have drug-resistant tuberculosis. 1,603 service providers also received training on DR-TB management from inception till March 2016.
The Institute has built a Bio-Safety Level 3 laboratory in the National TB Leprosy Training Center in Zaria, Nigeria, one of the first of its kind in Africa. With this, multi-drug resistant tuberculosis and other illnesses are being diagnosed in the country
IHVN has been implementing the Global Fund Malaria program, as a Sub-Recipient to the National Malaria Elimination Program (NMEP) from 2009 till date. Over the past 7 years, the institute has supported the components of malaria control interventions through selected public health facilities in 13 States- Katsina, Ogun, Kwara, Gombe, Akwa-Ibom, Kano, Kaduna, Borno, Kebbi, Plateau, Kogi, Benue and Jigawa States. Cumulatively, 417 public health facilities across 291 LGAs were supported to deliver free prompt and effective malaria services in their various communities.
Till date, IHVN has distributed over 5 million Long Lasting Insecticide Treated Nets through campaigns and routine /continuous distribution channels. About 9.8 million persons have been treated with ACTs and over 7 million parasitological diagnosis done before treatment. With the inclusion of IPTp during the just concluded NFM, 730,271 pregnant women benefited from routine SPs as IPTp for prevention of Malaria in Pregnancy.
IHVN in collaboration with the Nigerian Federal Ministry of Health (FMOH) and the International Agency for Research on Cancer (IARC) has organized trainings in cancer registration for 25 institutions in Nigeria.The Institute has taken a lead in coordinating cancer registration in Nigeria. It currently hosts the National System of Cancer Registries (NSCR). NSCR was conceived in 2009, as a collaborative effort between IHVN, Federal Ministry of Health (FMOH), and cancer registries of federal health institutions in Nigeria. The main objective of this program is to provide data from Nigerian cancer registries on the most common cancers, cancer incidence and cancer mortality statistics. For more information, click here
The Institute is also participating in a multi-institutional research funded by the National Institutes of Health to develop a better understanding of cervical cancer and the processes involved in the development of the disease. To this end, free cervical cancer screening is being offered in seven hospitals in the country. These hospitals are, Asokoro District Hospital, National Hospital Abuja, Garki Hospital Abuja, Federal Medical Center Keffi, Kubwa General Hospital, Wuse General Hospital and University of Abuja Teaching Hospital. Cervical cancer screening is done at these sites using HPV/DNA testing which is the most sensitive method for screening. For more information, click here
The Institute has trained health care workers to on ante-retroviral treatment, strategic information, care and support, prevention, laboratory services and equipment maintenance, blood safety, HIV counselling and testing, pharmocovigilance, and malaria and cancer prevention, management and control. 31,887 people have been trained to provide quality services. IHVN also has accreditation to offer Continuing Professional Development Program for medical doctors to acquire credits for the annual renewal of their license. Our training centers and halls are also equipped to handle training sessions. For more information, click here
IHVN conducts biomedical research focusing on HIV/AIDS, tuberculosis, cancer and other non-communicable diseases. The Institute has also been a contributor to scientific literature by publishing in several international peer review journals. For more information on the major research projects the Institute is implementing, click here
The activities of the Institute are funded by international organizations which include:
Centers for Disease Control and Prevention (CDC)
The Global Fund to fight AIDS, Tuberculosis and Malaria (GF)
University of Maryland, Baltimore USA (UMB)
United States' National Institute for Health (NIH)
International Development Research Center (IDRC)
World Health Organization
Locally, IHVN is a sub-recipient to FHI 360 in the provision of HIV testing services, prevention of mother-to-child transmission of HIV anti-troviral treatment services and TB/HIV interventions.